Reference: FOI 25883 CHI 10H
Subject: Patient Care
I can confirm that the CCG does hold some of information requested; please see responses below:
QUESTION
Buckinghamshire CCG
I would like to request the information about the following points around the CCG's decisions with patient care and its
structure.
The CCG can confirm that it does hold this information, but is exempting it
under
Section 21 Freedom of Information Act 2000 as it is reasonably
accessible by other means. This is an absolute exemption.
• What criteria does the CCG use to select which
I have provided you with a link to our website which will provide you with
inhalers should be prescribed for Asthma and
this information:
COPD?
http://www.bucksformulary.nhs.uk/chaptersSub.asp?FormularySectionID=3
Please note that the Asthma guidelines are currently being reviewed in
view of conflicting advice from BTS/NICE.
1
• How does the CCG compare the cost-
effectiveness , efficacy, safety and patient
usability of different inhalers when selecting
Products are reviewed at Formulary Management Committee.
which COPD and Asthma inhalers should be
included on its local guidance?
• Over the past three years, has the CCG
introduced a planned programme of care which
resulted in the medicines optimisation team,
No
contractors or GP practices proactively reviewing
patients and aligning their COPD and/or Asthma
inhalers to alternative options?
The CCG can confirm that it does hold this information, but is exempting it
under
Section 21 Freedom of Information Act 2000 as it is reasonably
accessible by other means. This is an absolute exemption.
• Please list the alternative asthma and COPD
inhalers that were introduced by the CCGs
I have provided you with a link to our website which will provide you with
medicines optimisation team, contractors or GP
this information:
practices during any planned programme of care
that proactively reviewed the use of asthma
http://www.bucksformulary.nhs.uk/chaptersSub.asp?FormularySectionID=3
and/or COPD inhalers over the past 3 years .
Please note that the Asthma guidelines are currently being reviewed in
view of conflicting advice from BTS/NICE.
2
• Over the past three years, has the CCG used a
QIPP scheme to introduce a planned programme
of care which resulted in the medicines
Use has been made of the Primary Care Development Scheme for this
optimisation team, contractors or GP practices
purpose.
proactively reviewing patients and aligning their
COPD and/or Asthma inhalers to alternative
options?
The CCG can confirm that it does hold this information, but is exempting it
under
Section 21 Freedom of Information Act 2000 as it is reasonably
accessible by other means. This is an absolute exemption.
• Please list the alternative asthma and COPD
inhalers that were introduced by the CCGs
I have provided you with a link to our website which will provide you with
medicines optimisation team, contractors or GP
this information:
practices when using a QIPP scheme to introduce
a planned programme of care that proactively
http://www.bucksformulary.nhs.uk/chaptersSub.asp?FormularySectionID=3
reviewed the use of asthma and/ or COPD
inhalers over the past 3 years?
Please note that the Asthma guidelines are currently being reviewed in
view of conflicting advice from BTS/NICE.
The information provided in this response is accurate as of 24 April 2018, and has been authorised for release by Nicola
Lester, Director of Transformation for NHS Buckinghamshire CCG.
3